TY - JOUR
T1 - Preparation of anti-orotate phosphoribosyltransferase antibody and its application to immunochemical detection in human tumor cells.
AU - Sakamoto, Kazuki
AU - Sugimoto, Yoshikazu
AU - Miyadera, Kazutaka
AU - Oka, Toshinori
AU - Fukushima, Masakazu
PY - 2005/8
Y1 - 2005/8
N2 - Orotate phosphoribosyltransferase (OPRT) is a key enzyme in the anabolism of 5-fluorouracil (5-FU), and its expression in tumors is thought to increase the efficacy of 5-FU against the tumor. To detect the OPRT protein by immunoblot and/or immunohistochemical methods, we prepared highly specific antibody to the peptides contained in the human OPRT amino acid sequence. The anti-OPRT polyclonal antibodies, obtained by immunizing rabbits with the OPRT peptides, had a high specificity for the OPRT protein in human tumor xenografts when it was analyzed by immunoblotting, and furthermore, there was a positive correlation between OPRT activity and protein content in 12 human tumors (R2 = 0.632). These results suggest that immunohistochemical detection of tumoral OPRT protein expression with our anti-OPRT antibodies may provide a useful method for predicting the clinical response to 5-FU-based chemotherapy.
AB - Orotate phosphoribosyltransferase (OPRT) is a key enzyme in the anabolism of 5-fluorouracil (5-FU), and its expression in tumors is thought to increase the efficacy of 5-FU against the tumor. To detect the OPRT protein by immunoblot and/or immunohistochemical methods, we prepared highly specific antibody to the peptides contained in the human OPRT amino acid sequence. The anti-OPRT polyclonal antibodies, obtained by immunizing rabbits with the OPRT peptides, had a high specificity for the OPRT protein in human tumor xenografts when it was analyzed by immunoblotting, and furthermore, there was a positive correlation between OPRT activity and protein content in 12 human tumors (R2 = 0.632). These results suggest that immunohistochemical detection of tumoral OPRT protein expression with our anti-OPRT antibodies may provide a useful method for predicting the clinical response to 5-FU-based chemotherapy.
UR - http://www.scopus.com/inward/record.url?scp=32944464583&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=32944464583&partnerID=8YFLogxK
U2 - 10.3892/ijmm.16.2.245
DO - 10.3892/ijmm.16.2.245
M3 - Article
C2 - 16012756
AN - SCOPUS:32944464583
SN - 1107-3756
VL - 16
SP - 245
EP - 249
JO - International Journal of Molecular Medicine
JF - International Journal of Molecular Medicine
IS - 2
ER -